Crossmark

Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes

Crossref DOI link: https://doi.org/10.1007/s11302-019-09649-2

Published Online: 2019-04-25

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nassir, Molhm

Arad, Uri

Lee, Sang-Yong

Journo, Shani

Mirza, Salahuddin

Renn, Christian

Zimmermann, Herbert

Pelletier, Julie

Sévigny, Jean

Müller, Christa E.

Fischer, Bilha http://orcid.org/0000-0001-8837-0978
License Information

Text and Data Mining valid from 2019-04-25
More Information

Article History

Received: 20 November 2018

Accepted: 6 February 2019

First Online: 25 April 2019

Change Date: 20 July 2019

Change Type: Correction

Change Details: The original version of the article unfortunately contained an error.

Compliance with ethical standards

:

: Molhm Nassir declares that he has no conflict of interest.Uri Arad declares that he has no conflict of interest.Sang-Yong Lee declares that he/she has no conflict of interest.Shani Journo declares that he has no conflict of interest.Salahuddin Mirza declares that he has no conflict of interest.Christian Renn declares that he has no conflict of interest.Christa E. Müller declares that she has no conflict of interest.Bilha Fischer declares that she has no conflict of interest.

: The study was approved by the institutional ethics committee according to the Declaration of Helsinki. All patients provided written informed consent.